Merit Medical Systems, Inc. (NASDAQ:MMSI) Receives Consensus Rating of “Moderate Buy” from Analysts

Merit Medical Systems, Inc. (NASDAQ:MMSI) has earned a consensus recommendation of “Moderate Buy” from the eleven ratings firms that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and eight have assigned a buy recommendation to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $92.80.

A number of research firms recently weighed in on MMSI. Citigroup restated an “outperform” rating on shares of Merit Medical Systems in a research note on Monday, April 20th. Robert W. Baird set a $83.00 price target on Merit Medical Systems in a report on Friday, May 1st. Canaccord Genuity Group cut their price target on Merit Medical Systems from $90.00 to $85.00 and set a “buy” rating for the company in a report on Friday, May 1st. Piper Sandler dropped their target price on Merit Medical Systems from $106.00 to $96.00 and set an “overweight” rating for the company in a research note on Friday, April 17th. Finally, Wall Street Zen lowered Merit Medical Systems from a “strong-buy” rating to a “buy” rating in a research note on Sunday, April 5th.

Insider Transactions at Merit Medical Systems

In other news, insider Brian G. Lloyd bought 2,000 shares of the firm’s stock in a transaction dated Thursday, May 7th. The stock was acquired at an average price of $62.62 per share, for a total transaction of $125,240.00. Following the acquisition, the insider owned 2,000 shares of the company’s stock, valued at $125,240. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Lynne N. Ward sold 5,000 shares of the business’s stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $62.61, for a total value of $313,050.00. Following the sale, the director owned 7,809 shares of the company’s stock, valued at $488,921.49. The trade was a 39.04% decrease in their position. The SEC filing for this sale provides additional information. 0.70% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Merit Medical Systems

A number of large investors have recently modified their holdings of MMSI. Tudor Investment Corp ET AL acquired a new stake in shares of Merit Medical Systems in the third quarter valued at about $2,913,050,000. Wellington Management Group LLP grew its stake in shares of Merit Medical Systems by 377.7% in the third quarter. Wellington Management Group LLP now owns 1,240,509 shares of the medical instruments supplier’s stock valued at $103,248,000 after buying an additional 980,823 shares in the last quarter. Norges Bank acquired a new stake in shares of Merit Medical Systems in the fourth quarter valued at about $75,957,000. Thrivent Financial for Lutherans grew its stake in shares of Merit Medical Systems by 250.5% in the third quarter. Thrivent Financial for Lutherans now owns 750,066 shares of the medical instruments supplier’s stock valued at $62,428,000 after buying an additional 536,072 shares in the last quarter. Finally, Iron Triangle Partners LP acquired a new stake in shares of Merit Medical Systems in the fourth quarter valued at about $33,992,000. Institutional investors and hedge funds own 99.66% of the company’s stock.

Merit Medical Systems Trading Down 1.0%

Shares of MMSI stock opened at $63.09 on Monday. The business’s 50 day moving average is $66.31 and its two-hundred day moving average is $76.95. Merit Medical Systems has a twelve month low of $59.74 and a twelve month high of $96.74. The company has a market capitalization of $3.76 billion, a P/E ratio of 27.31, a price-to-earnings-growth ratio of 1.98 and a beta of 0.58. The company has a current ratio of 5.08, a quick ratio of 3.46 and a debt-to-equity ratio of 0.45.

Merit Medical Systems (NASDAQ:MMSI) last posted its quarterly earnings results on Thursday, April 30th. The medical instruments supplier reported $0.94 earnings per share for the quarter, beating analysts’ consensus estimates of $0.84 by $0.10. Merit Medical Systems had a return on equity of 13.54% and a net margin of 9.03%.The firm had revenue of $381.88 million for the quarter, compared to the consensus estimate of $377.59 million. During the same period in the previous year, the business earned $0.86 earnings per share. The company’s revenue for the quarter was up 7.4% compared to the same quarter last year. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. Equities analysts forecast that Merit Medical Systems will post 3.62 EPS for the current year.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.